Commercial Launch

Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEAL™ Embolization System has received CE Mark certification...

BERKELEY HEIGHTS, N.J., July 13, 2026 Tonix Pharmaceuticals announced a major managed Medicare payer agreement that will expand pharmacy...

IRVINE, Calif., USA — April 1, 2026 JenaValve Technology, Inc. has announced the U.S. commercial launch of its Trilogy®...

FORT LEE, N.J., October 9, 2025 — Kedrion Biopharma today announced the U.S. commercial launch of YIMMUGO® (Immune Globulin...

NEEDHAM, Mass., October 9, 2025 — Stealth BioTherapeutics Inc. has announced the launch of Mito Assist™, a comprehensive patient...

MINNEAPOLIS, August 29, 2025 — Phraxis announced the successful completion of the first-ever commercial case using its EndoForce Anastomotic...